Vince Simmon had speculated that the patent portfolio alone was, in his opinion, worth about $5 per share. That was in a conversation with him two years earlier.
How would estimate the value of Cortex's patent portfolio?
The experiments must first prove safety and efficacy. After that is established, which is a hurdle for Cortex, the results must be statistically verifiable. One of the key statistical measures is how effective a drug is compared with anticipated results without using that drug or -- importantly in the case of ampakines -- compared with using similar or predicate drugs.
Market Data 
Markets 
AI
